Scout | DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award

This opportunity is no longer accepting applications.

grant

DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award

The FY24 ALSRP Therapeutic Development Award funds research for therapies targeting ALS, from preclinical validation to FDA IND-enabling studies. Projects should be empirical and product-focused, starting with lead compounds and proof-of-concept data in ALS models. Applicants are encouraged to collaborate with ALS experts. The grant supports the development of predictive biomarkers alongside t…

Source

Agency: Dept. of the Army -- USAMRAA

Program: SBIR

Award

Total Funding: $9.6M

Total Awards Given 4

Dates

Opportunity Released: March 25, 2024

Open for Submission: March 25, 2024

Submission Deadline: July 10, 2024

Application Window Closes: July 10, 2024

Keywords

ALS

therapeutic development

preclinical validation

FDA IND-enabling studies

empirical research

proof-of-concept efficacy

ALS model systems

pharmacodynamic biomarkers

drug discovery

clinical outcomes.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers